News

The study was a phase II safety, efficacy and absorption evaluation of ARYS-01 cream with the test material applied twice daily for 7 days in patients with a

The key to boosting the vaccines is by extending the lives of dendritic cells, the immune-system master switches that promote the response of T-cells, which attack tumors. “By

In early trading Pfizer’s shares fell more than 10% in Frankfurt. A monitoring board recommended terminating the study because of an imbalance of mortality and cardiovascular events. Patient

The risk of heart attack can be reduced by more than 50% by combining a cholesterol-reducing drug, atorvastatin calcium, with a blood pressure-lowering drug amlodipine besylate, a calcium

New data from a phase II trial of patients with Crohn’s disease analyzed the effect of Traficet-EN on lowering pro-inflammatory cytokine and chemokine concentrations in the intestine. These

The two phase II clinical trials were evaluating adecatumumab as a single agent for the treatment of patients with metastatic breast cancer and prostate cancer. Micromet and Serono

For early-stage breast cancer, the standard treatment is a lumpectomy followed by radiation therapy. When to give the chemotherapy has been widely debated among researchers. The outcome for

The Securities and Exchange Commission (SEC) investigation commenced in March 2004 and NeoPharm believes it concerned disclosures regarding the development of two drug candidates. The decision of the

The study was designed to investigate the absolute bioavailability, and the effects of food on the bioavailability, of two oral formulations of CK-1827452. Pharmacokinetic data from this study